ImageneBio (IMA) EBT (2020 - 2025)

ImageneBio has disclosed EBT across 6 years of filings, most recently posting -$24.9 million for Q3 2025.

• In Q3 2025, EBT fell 680.8% year-over-year to -$24.9 million; the TTM figure through Sep 2025 stood at -$55.8 million (down 6.12% YoY), while the FY2024 annual figure was -$49.1 million, up 28.17% from the prior year.
• EBT came in at -$24.9 million for Q3 2025 at ImageneBio, down from -$7.6 million in the prior quarter.
• In the past five years, EBT ranged from a high of $2.8 million in Q4 2021 to a low of -$24.9 million in Q3 2025.
• Average EBT over 5 years is -$13.7 million, with a median of -$14.5 million recorded in 2021.
• Year-over-year, EBT soared 110.74% in 2021 and plunged 680.8% in 2025.
• Over 5 years, EBT stood at $2.8 million in 2021, then plunged by 604.0% to -$14.1 million in 2022, then tumbled by 39.4% to -$19.7 million in 2023, then grew by 11.83% to -$17.3 million in 2024, then tumbled by 43.44% to -$24.9 million in 2025.
• Per Business Quant data, the three most recent EBT figures were -$24.9 million in Q3 2025, -$7.6 million in Q2 2025, and -$6.1 million in Q1 2025.